GUERF News and Press, Guerbet SA From 01/16/23

2023 Strategic Priorities Diagnostic Imaging : increase Elucirem TM sales and strengthen international positions Interventional Imaging : prioritise Lipiodol sales with the development of innovative indications Artificial Intelligence: execution of the roadma...

GUERBET press release ( OTC:GUERF ): 1H Revenue of €371.1M (+2.2% Y/Y). Outlook: The Group is confirming its ambitions for 2022. It expects revenue growth, between 2% and 4% on a like-for-like basis and at constant exchange rates. Regarding operating...

GUERBET press release (OTC:GUERF): Q1 Revenue of €181.1M (+2.7% Y/Y). The Group is confirming its ambitions for 2022 and expects further revenue growth, between 2% and 4% on a like-for-like basis and at constant exchange rates; regarding operating profit, given the inflationary en...

GUERBET ( OTC:GUERF ): 1H Net income of €19M. More news on: GUERBET SA ORD, Earnings news and commentary, , Read more ...

GUERBET ( OTC:GUERF ): FY Net income of €46.8M. More news on: GUERBET SA ORD, Earnings news and commentary, Read more ...